We are live on
!
Find out more
ACL
APEIRON Capital Ltd Portfolio holdings
AUM
$156M
1-Year Est. Return
183.17%
This Fund
S&P 500
This Quarter
Est. Return
+20.58%
1 Year Est. Return
+183.17%
3 Year Est. Return
+486.87%
5 Year Est. Return
+343.15%
10 Year Est. Return
–
AUM
$309M
AUM Growth
+$76.3M
(+33%)
Cap. Flow
+$35.2M
Cap. Flow
% of AUM
11.41%
Top 10 Holdings %
Top 10 Hldgs %
98.61%
Holding
11
New
2
Increased
7
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DOCU
DocuSign
DOCU
|
+$12.7M |
| 2 |
Moderna
MRNA
|
+$8.4M |
| 3 |
Sea Limited
SE
|
+$3.96M |
| 4 |
Amazon
AMZN
|
+$3.32M |
| 5 |
Microsoft
MSFT
|
+$2.54M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 47.17% |
| 2 | Healthcare | 33.1% |
| 3 | Technology | 13.76% |
| 4 | Financials | 5.98% |
Similar funds
RWC
SC
JAA
BF
FLP
RB
CP
CWM
APEIRON Capital Ltd's Q2 2021 Portfolio in Review
As of Q2 2021, APEIRON Capital Ltd held 11 positions worth $309M, up 33% from $233M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
APEIRON Capital Ltd deployed $35.2M of net new capital in Q2 2021, opening 2 new positions and adding to 7 existing holdings. Its largest new stake was DocuSign: 56,700 shares worth $15.9M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 47% of assets, down from 56% a quarter earlier, followed by Healthcare and Technology.
- APEIRON Capital Ltd's largest Q2 2021 buy was DocuSign: 56,700 shares worth $15.9M.
- APEIRON Capital Ltd added most to Moderna in Q2 2021, an estimated $8.4M increase.
- APEIRON Capital Ltd's ten largest holdings make up 99% of its $309M portfolio in Q2 2021.
- APEIRON Capital Ltd opened 2 new positions and closed 0 in Q2 2021.
- APEIRON Capital Ltd's portfolio value rose 33% quarter-over-quarter to $309M.
Based on APEIRON Capital Ltd's 13F filing for Q2 2021, filed 14 Jul 2021.